- Global Pharma News & Resources

Press Releases - 2019-06-26

Date Title Company
26-Jun-2019 ESSA Provides an Update to the Acquisition of Realm Therapeutics ESSA Pharma Inc
26-Jun-2019 FDA approves first treatment for chronic rhinosinusitis with nasal polyps U.S. Food and Drug Administration
26-Jun-2019 FDA Approves Dupixent® (dupilumab) for Chronic Rhinosinusitis with Nasal Polyposis Regeneron Pharmaceuticals, Inc.
26-Jun-2019 curasan AG: Annual General Meeting 2019 curasan AG
26-Jun-2019 MammaPrint® Becomes Only Molecular Diagnostic Recommended for Early-Stage Node-Positive Breast Cancer Patients in ASCO-Endorsed Cancer Care Ontario Guidelines B3C newswire
26-Jun-2019 J+D Forecasting Launches Innovative Oncology Forecasting Software J+D Forecasting
26-Jun-2019 AbbVie attempts to secure long-term growth via Allergan mega-merger, says GlobalData AbbVie
26-Jun-2019 XBiotech Wins “Commercial Real Estate Award for Industrial Development” for its Headquarters in Austin, Texas XBiotech
26-Jun-2019 Exclusive Interview with Stephen Murby of ASBM Released Ahead of Upcoming Biosimilars Conference SMi Group Ltd
26-Jun-2019 Major shareholder announcement for Genmab A/S Genmab A/S
26-Jun-2019 XBiotech Announces Dr. Alice Gottlieb to Chair Upcoming Phase 2 Study of Bermekimab in Hidradenitis Suppurativa XBiotech
26-Jun-2019 Premark Pharma Licenses Worldwide Rights to PMP2207 for Ophthalmic Indications and Targets a First Regulatory Approval for Blepharitis Premark Pharma
26-Jun-2019 EpicentRx Announces Publication of Its Positive Phase 2 3rd Line SCLC Results With RRx-001 Plus a Platinum Doublet in the British Journal of Cancer (BJC) EpicentRx
26-Jun-2019 Medics4RareDiseases becomes a UK Registered Charity Medics4RareDiseases
26-Jun-2019 Vesalius Biocapital III Announces Final Close of EUR 120 million Fund Vesalius Biocapital III
26-Jun-2019 Independent Pharmacy Alliance of America (IPA) and Leading Edge Pharms Ink Deal to Bring Topical Hemp/CBD to Member Pharmacies Leading Edge Pharms, Inc. (LEP)
26-Jun-2019 EMA Validates Santhera’s Marketing Authorization Application for Puldysa® in Duchenne Muscular Dystrophy Pratteln, Switzerland, June 25, 2019 Santhera
26-Jun-2019 Dutch Scale-up SkylineDx Secures Respected CAP/CLIA Certification for US Laboratory SkylineDx
26-Jun-2019 Worldwide Ablation Market 2019 with Research Methodology Wired Release
26-Jun-2019 Advanced Wound Care Market 2019 – Segmented Market Growth Till 2028 Wired Release